Establishment Labs Holdings Inc. (FRA:3E0)

Market Cap	1.63B +97.7%
Revenue (ttm)	179.77M +27.1%
Net Income	-43.49M
EPS	-1.47
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3
Open	54.90
Previous Close	56.50
Day's Range	54.88 - 54.90
52-Week Range	25.60 - 66.50
Beta	n/a
RSI	55.88
Earnings Date	May 6, 2026

About FRA:3E0

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and i...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2004
• Employees: 1,004
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 3E0

Financial Performance

In 2025, FRA:3E0's revenue was $211.08 million, an increase of 27.14% compared to the previous year's $166.03 million. Losses were -$51.06 million, -39.64% less than in 2024.

Financial numbers in USD